The present invention provides methods of treating neurological disorders in a mammal by administering to the mammal an effective amount of a selective persistent sodium channel antagonist that has at least 20-fold selectivity for persistent sodium current relative to transient sodium current.

 
Web www.patentalert.com

< Protein kinase inhibitors

< Antisense modulation of connective tissue growth factor expression

> Tetrahydroquinoline derivatives useful as serine protease inhibitors

> Combinations and kits for cancer treatment using selected antibodies to aminophospholipids
~ 00602